Senestech, Inc. (SNES) Stock Price & Analysis
Senestech, Inc. (SNES) fell 0.71% to USD 1.39 as of July 25, 2026 at 10:41 UTC, according to Nexqual real-time market data.
SNES last closed at USD 1.4; the session ranged USD 1.37–1.43 on volume of 39,471 shares. Market capitalization is $7.37M, with a 52-week range of USD 1.34–6.24 (NCM). Source: Nexqual, July 25, 2026 at 10:41 UTC.
Key Statistics (as of July 25, 2026 at 10:41 UTC)
| Price | USD 1.39 |
|---|---|
| Change | ▼ 0.71% (down) |
| Previous Close | USD 1.4 |
| Open | USD 1.43 |
| Day Range | USD 1.37 – 1.43 |
| 52-Week Range | USD 1.34 – 6.24 |
| Volume | 39,471 shares |
| Market Cap | $7.37M |
| Exchange | NCM |
Technical Analysis (SNES)
Nexqual's technical model rates SNES "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 10:41 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.61 (neutral) |
| vs SMA50 | Below (USD 1.58) |
| MACD | -0.05 (negative) |
Analyst Ratings (SNES)
Wall Street analysts rate SNES "None" based on 2 analysts, with a mean price target of USD 6.75 (range USD 3.5–10), per Nexqual as of July 25, 2026 at 10:41 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 6.75 |
| High Target | USD 10 |
| Low Target | USD 3.5 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (SNES)
| Next Earnings Date | 2026-08-06 |
|---|---|
| Revenue Estimate | $601,500 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.35 vs est -0.3 ▼ miss |
| 2025-09-30 | USD -0.28 vs est -0.35 ▲ beat |
Source: Nexqual, July 25, 2026 at 10:41 UTC.
Financials & Fundamentals (SNES)
| Total Revenue | $2.23M |
|---|---|
| Revenue Growth (YoY) | +1.60% |
| Gross Margin | +63.39% |
| Operating Margin | -429.82% |
| Profit Margin | +0.00% |
| ROE | -128.03% |
| Debt / Equity | 34.14 |
| Current Ratio | 8.91 |
| Total Cash | $6.80M |
| Total Debt | $2.63M |
| Free Cash Flow | $-3.94M |
Source: Nexqual, July 25, 2026 at 10:41 UTC.
Financial Health Score (SNES)
Nexqual rates Senestech, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 10:41 UTC.
| Growth | Strong — Revenue +20% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $7M cash vs $3M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -128%, ROA -59.2% |
Ownership (SNES)
| Insider Ownership | +4.21% |
|---|---|
| Institutional Ownership | +30.06% |
| Shares Outstanding | 5.30M |
| Float | 4.01M |
| Short % of Float | +0.61% |
Source: Nexqual, July 25, 2026 at 10:41 UTC.
Leadership (SNES)
Senestech, Inc. is led by Michael Edell (age 61), President & CEO, per Nexqual as of July 25, 2026 at 10:41 UTC.
| President & CEO | Michael Edell (age 61) |
|---|---|
| Executive VP, CFO, Treasurer & Secretary | Thomas C. Chesterman (age 66) |
Major Backers & Investors (SNES)
Notable institutional backers of Senestech, Inc. include Sabby Management, LLC, Renaissance Technologies, Fidelity, according to Nexqual as of July 25, 2026 at 10:41 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sabby Management, LLC | 4.12% |
| Renaissance Technologies | 2.15% |
| Fidelity | 0.94% |
| Essex Investment Management Co LLC | 0.5% |
| Xtx Topco Ltd | 0.4% |
| UBS Group AG | 0.39% |
| Diversify Wealth Management, LLC | 0.36% |
| Jane Street Group, LLC | 0.31% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.22% |
| Geode Capital | 1.19% |
Source: Nexqual, July 25, 2026 at 10:41 UTC.
From Senestech, Inc.'s Latest SEC 10-K Filing (filed 2026-03-13)
Key Strengths & Strategy (as disclosed to the SEC)
- SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
- The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption.
- It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPCB | SuperCom, Ltd. | USD 10.71 | ▼ 2.1% |
| TENX | Tenax Therapeutics, Inc. | USD 14.53 | ▼ 1.76% |
| XMAX | XMAX, Inc. | USD 8.43 | ▼ 1.98% |
| XBIO | Xenetic Biosciences, Inc. | USD 2.64 | ▼ 1.12% |
| LMFA | LM Funding America, Inc. | USD 2.6 | ▲ 18.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 10:41 UTC. This page is informational and not investment advice.